Totoy, Michelle C.
HRN: 07-36-20 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/08/2025
CEFUROXIME 1.5GM (VIAL)
06/08/2025
06/14/2025
IVT
1.5gms
Q8
S/P Hysterectomy
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes